Syndax Pharmaceuticals IncSNDX

Market cap

$1.3B

P/E ratio

	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Total revenues	1	2	2	2	2	140	-
Research and development	32	48	60	43	50	88	118
General and administrative	13	16	17	16	23	25	33
Total operating expenses	45	64	77	59	73	113	152
(Loss) income from operations	-44	-62	-76	-58	-71	26	-152
Interest expense	-	-	-	-	2	2	3
Interest income	-	-	-	-	1	0	6
Other (expense) income:	0	-0	-0	-0	-0	0	-0
Total other income (expense)	-1	1	2	1	-2	-1	2
Net (loss) income	-44	-61	-74	-56	-73	25	-149
Net (loss) income attributable to common stockholders	-47	-61	-74	-56	-77	25	-149
Earnings Per Share, Basic	-	-	-	-	-	0.48	-2.46
Earnings Per Share, Diluted	-	-	-	-	-	0.46	-2.46